Evidence map›Paper›PMID 39459410›Full record

ArticleMedicina (Kaunas, Lithuania)2024

Multicentral Retrospective Analysis of Venetoclax-Based Treatments in AML and MDS: A Real-World Study by the Turkish Hematology Network Group.

Ibrahim Halil Acar, Muzeyyen Aslaner Ak, Gulsah Akyol, Taha Ulutan Kars, Yildiz Ipek, Ayse Uysal, Figen Atalay, Aysun Senturk Yikilmaz, Omer Ekinci, Idris Ince and 7 more

Abstract readMulticenter Study
In one paragraph

Article in Medicina (Kaunas, Lithuania), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Ibrahim Halil AcarHematology Clinic, Osmaniye State Hospital, 80000 Osmaniye, Türkiye.ORCID 0000-0002-8657-1407
Muzeyyen Aslaner AkDepartment of Hematology, Faculty of Medicine, Zonguldak Bulent Ecevit University, 67100 Zonguldak, Türkiye.
Gulsah AkyolDivision of Hematology, Department of Internal Medicine, Faculty of Medicine, Erciyes University, 38030 Kayseri, Türkiye.
Taha Ulutan KarsHematology Clinic, Konya City Hospital, Health Sciences University, 42020 Konya, Türkiye.ORCID 0000-0003-4013-4647
Yildiz IpekHematology Clinic, Istanbul Kartal Dr. Lutfi Kirdar City Hospital, 34865 Istanbul, Türkiye.ORCID 0000-0003-2952-2286
Ayse UysalDivision of Hematology, Department of Internal Medicine, Faculty of Medicine, Fırat University, 23200 Elazıg, Türkiye.ORCID 0000-0002-5581-8104
Figen AtalayDivision of Hematology, Department of Internal Medicine, Faculty of Medicine, Yeditepe University, 34718 Istanbul, Türkiye.
Aysun Senturk YikilmazHematology Clinic, Denizli State Hospital, 20010 Denizli, Türkiye.ORCID 0000-0001-5281-5955
Omer EkinciDepartment of Adult Bone Marrow Transplantation, Kolan International Hospital, 34384 Istanbul, Türkiye.
Idris InceHematology Clinic, Gaziantep City Hospital, 27470 Gaziantep, Türkiye.
Birgul OnecDivision of Hematology, Department of Internal Medicine, Faculty of Medicine, Duzce University, 81010 Duzce, Türkiye.
Hakan KeskiHematology Clinic, Umraniye Training and Research Hospital, Health Sciences University, 34760 Istanbul, Türkiye.ORCID 0000-0002-5644-823X
Mufide Okay OzgeyikHematology Clinic, Eskisehir City Hospital, Health Sciences University, 26080 Eskisehir, Türkiye.
Sebnem Izmir GunerDepartment of Adult Bone Marrow Transplantation, Hisar Hospital Intercontinental, 34768 Istanbul, Türkiye.
Esra Terzi DemirsoyDivision of Hematology, Department of Internal Medicine, Faculty of Medicine, Kocaeli University, 41001 Kocaeli, Türkiye.
Oktay BilgirHematology Clinic, Bozyaka Training and Research Hospital, Health Sciences University, 35170 Izmir, Türkiye.ORCID 0000-0001-9579-0583
Birol GuvencDepartment of Hematology, Faculty of Medicine, Adana Çukurova University, 01790 Adana, Türkiye.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Bridged Bicyclo Compounds, HeterocyclicLeukemia, Myeloid, AcuteMyelodysplastic SyndromesSulfonamidesAdultAgedAged, 80 and overAntineoplastic AgentsFemaleHumansMaleMiddle AgedRetrospective StudiesSurvival AnalysisTurkeyAntineoplastic AgentsBridged Bicyclo Compounds, HeterocyclicSulfonamidesvenetoclaxacute myeloid leukemiamalignancymyelodysplastic syndrometreatment outcomevenetoclax

Identifiers

PMID39459410
PMCPMC11509471

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.